Literature DB >> 30146837

Emergence of IMP-4-Producing Enterobacter aerogenes Clinical Isolate.

Jong Ho Lee, Chae Hoon Lee, Il Kwon Bae.   

Abstract

BACKGROUND: IMP-4 class B metallo-β-lactamase-producing Enterobacteriaceae are resistant to carbapenems. The aim of this study was to characterize of IMP-4 metallo-β-lactamase (MBL)-producing Enterobacter aerogenes clinical isolate.
METHODS: IMP-4 MBL-producing E. aerogenes clinical isolate was collected from a Korean Hospital in 2017. Antimicrobial susceptibility was determined by disk diffusion methods. Further, minimum inhibitory concentrations of β-lactams were determined by Etest. Detection of bla genes was performed by PCR. The genetic organization of class 1 integron carrying the MBL gene cassette was investigated by PCR mapping and sequencing.
RESULTS: E. aerogenes strain YN170501 exhibited resistance to penicillins, cephalosporins, and carbapenems and was susceptible to monobactam, aminoglycosides, fluoroquinolone, tigecycline, and trimethoprim-sulfamethoxazole. The blaIMP-4 gene was located in class 1 integron.
CONCLUSIONS: The blaIMP-4 gene has never been reported in Enterobacter aerogenes clinical isolate from Korea.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30146837     DOI: 10.7754/Clin.Lab.2018.180211

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  3 in total

1.  Emergence of NDM-5 Producing Carbapenem-Resistant Klebsiella aerogenes in a Pediatric Hospital in Shanghai, China.

Authors:  Fen Pan; Qi Xu; Hong Zhang
Journal:  Front Public Health       Date:  2021-02-25

2.  IncN1 ST7 Epidemic Plasmid Carrying blaIMP-4 in One ST85-Type Klebsiella oxytoca Clinical Isolate with Porin Deficiency.

Authors:  Mingyue Sun; Weiqiang Xiao; Qingxia Xu
Journal:  Infect Drug Resist       Date:  2021-09-18       Impact factor: 4.003

3.  Characterization of an IMP-4-Producing Klebsiella pneumoniae ST1873 Strain Recovered from an Infant with a Bloodstream Infection in China.

Authors:  Juan Xu; Wenping Lin; Yanmin Chen; Fang He
Journal:  Infect Drug Resist       Date:  2020-03-09       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.